Winton Group
VERA icon

Winton Group’s Vera Therapeutics VERA Stock Holding History

Winton Group’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.87M Buy
+58,014
New +$2.03M 0.07% 268

Other funds holding VERA

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Winton Group's VERA Position: Q3 2026 in Review

Winton Group opened a new position in Vera Therapeutics (VERA) in Q3 2026: 58,014 shares worth $1.87M. The stake represents 0.07% of the portfolio and ranks #268 among its holdings.

147 funds tracked by Wall St. Rank hold VERA as of Q3 2026.

  • Winton Group held 58,014 shares of Vera Therapeutics worth $1.87M as of Q3 2026.
  • Vera Therapeutics was a new Winton Group position in Q3 2026.
  • Vera Therapeutics made up 0.07% of Winton Group's portfolio in Q3 2026, its #268 holding.
  • 147 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2026.

Based on Winton Group's 13F filing for Q3 2026, filed 12 Nov 2026.